Investigator Name: Joshua Kapp, MBBS, MD, MRCS
Organization: Amgen
Function: Clinical Research Medical Director
Role in GUIDE.MRD (brief description): Co-Chair of Work Package 3 (clinical studies)
Expectation of GUIDE.MRD (brief description): To advance the corpus of data supporting the integration of ctDNA-based MRD endpoints in clinical trials as well as improving adjuvant treatment for patients with solid tumors.
Telephone: + 1 805 338 8757
E-mail address: jkapp01@amgen.com
01 Universitaetsklinikum Hamburg-Eppendorf (UKE) – Germany
02 Aarhus Universitet (AU) – Denmark
03 Academisch Ziekenhuis Groningen (UMCG) – Netherlands
04 Centre Hospitalier Universitaire de Nice (CHUNICE) – France
05 Fundacion Sector Publico Estatal Centro Nacional Investigaciones Oncológicas Carlos III (FPS-CNIO) – Spain
06 LungenClinic Grosshansdorf GMBH (LUNGEN-CG) – Germany
07 Karolinska Institutet (KI) – Sweden
08 Illumina Cambridge Limited (ILLUMINA) – United Kingdom
09 Horizon Discovery Limited (HDL) – United Kingdom
10 LGC Clinical Diagnostics INC (LGC) – United States
11 The Synergist (SYNERGIST) – Belgium
12 Digestive Cancers Europe DICE (DiCE) – Belgium
13 Amgen (Europe) GMBH (AMGEN) – Switzerland
14 Bristol-Myers Squibb Company Corp (BMS) – United States
15 F. Hoffmann-La Roche AG (ROCHE) – Switzerland
16 Innovation Acta (INN-ACTA) – Italy
17 AstraZeneca UK Limited (AZ) – United Kingdom
18 Medizinische Universitat Graz (MUG) – Austria
19 Synergist Services (SYNERSERV) – Belgium
20 Asociatia Centrul Pentru Inovatie in Medicina (INOMED) – Romania
21 Centre Hospitalier Universitaire Montpellier (CHUM) – France
22 Aarhus Universitetshospital (AUH) – Denmark
23 Region Stockholm (KH) – Sweden
24 Lung Cancer Europe LUCE (LuCE) – Switzerland
25 AbbVie (AbbVie)
